Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

McIntyre RS

26 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 21 Review Article 16 Systematic Review 12 Treatment-Resistant Depression 11 Clinical Trial 10 Safety 9 Randomized Controlled Trial 6 Mechanism of Action 6 Anxiety 6 Receptor Pharmacology 5 PTSD 3 Brain Imaging 3

Journals

Journal of affective disorders 4 Canadian journal of psychiatry. Revue canadienne de psychiatrie 3 Psychiatry research 3 Progress in neuro-psychopharmacology & biological psychiatry 2 Journal of psychiatric research 2 Expert opinion on drug safety 2 CNS drugs 2 JAMA psychiatry 1

Publication history

Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic Review.JAMA psychiatry · 2026-07-01 The effect of dextromethorphan on reward-related behaviors: A systematic review of preclinical and clinical evidence.Journal of affective disorders · 2026-04-01 Cardiac Consequences Associated with Psychedelic Use: A Systematic Review of Lysergic Acid Diethylamide, 3,4-Methylenedioxymethamphetamine, and 5-Hydroxytryptamine 2B-Mediated Valvular Heart Disease.Pharmacopsychiatry · 2026-03-01 Ketamine, Psychedelics, and Psychotherapy: Reframing, Redefining, Renaming Treatment Models.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2026-02-01 Temporal dynamics in neuroimaging as correlates of therapeutic response to psilocybin in major depressive disorder: A systematic review and critical appraisal.Journal of affective disorders · 2026-01-15 Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trial.Progress in neuro-psychopharmacology & biological psychiatry · 2025-12-20 Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l'étude.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2025-10-01 Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depression.Journal of psychopharmacology (Oxford, England) · 2025-09-01 Non-hallucinogenic psychedelics for mood and anxiety disorders: A systematic review.Psychiatry research · 2025-07-01 Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II Disorder.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01 Protocols and practices in psilocybin assisted psychotherapy for depression: A systematic review.Journal of psychiatric research · 2024-08-01 Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review.Journal of affective disorders · 2024-06-15 A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic review.Journal of affective disorders · 2024-04-01 Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin.Med (New York, N.Y.) · 2024-03-08 Psilocybin-assisted therapy for depression: A systematic review and meta-analysis.Psychiatry research · 2023-11-01 Antidepressant Effects of Psilocybin in the Absence of Psychedelic Effects.The American journal of psychiatry · 2023-05-01 The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2023-01-01 Serotonin 5-HT receptor agonism and valvular heart disease: implications for the development of psilocybin and related agents.Expert opinion on drug safety · 2023-01-01 Is the psychedelic experience an essential aspect of the therapeutic effect of serotonergic psychedelics? Conceptual, discovery, development and implementation implications for psilocybin and related agents.Expert opinion on drug safety · 2023-01-01 A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review.CNS drugs · 2022-10-01 The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies.Psychiatry research · 2022-07-01 Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.CNS drugs · 2022-01-01 A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap.Journal of clinical psychopharmacology · 2022-01-01 Registered clinical studies investigating psychedelic drugs for psychiatric disorders.Journal of psychiatric research · 2021-07-01 The emerging role of psilocybin and MDMA in the treatment of mental illness.Expert review of neurotherapeutics · 2020-12-01 Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review.Progress in neuro-psychopharmacology & biological psychiatry · 2019-06-08

Author directory